Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers

@inproceedings{Adamski2010RiskSA,
  title={Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers},
  author={Jakub Adamski and Brian B Godman and Gabriella Ofierska-Sujkowska and Bogusława Osińska and Harald Herholz and Kamila Wendykowska and Ott Laius and Saira A. Jan and Catherine Sermet and Corrine Zara and Marija Kalaba and Roland Gustafsson and Kristina Garuolienė and Alan Haycox and Silvio Garattini and Lars L. Gustafsson},
  booktitle={BMC health services research},
  year={2010}
}
BACKGROUND There has been an increase in 'risk sharing' schemes for pharmaceuticals between healthcare institutions and pharmaceutical companies in Europe in recent years as an additional approach to provide continued comprehensive and equitable healthcare. There is though confusion surrounding the terminology as well as concerns with existing schemes. METHODS A literature review was undertaken to identify existing schemes supplemented with additional internal documents or web-based… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.
69 Citations
81 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 69 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 81 references

How much good do new medicines

  • A Walker, C Booth, A Brown, K Paterson
  • do? Basic & Clin Pharm & Toxicology
  • 2009
Highly Influential
6 Excerpts

Pharmaceutical risk-sharing and conditional reimbursement in Italy

  • P Folino Gallo, P Deambrosis
  • 2008 [http://www.ceestahc.org/ pliki/symp2008…
  • 2010
Highly Influential
10 Excerpts

Clozapine comes with money-back offer

  • P Anderson
  • [http:// www.mentalhealth.com/mag1/p51-cloz.html…
  • 2010
Highly Influential
4 Excerpts

Final appraisal determination bortezomib monotherapy for relapsed multiple myeloma

  • Anon NICE
  • [http://www.nice.org.uk/nicemedia/pdf/ FAD.pdf].
  • 2010
Highly Influential
4 Excerpts

Innovative approaches to pricing

  • Anon
  • IMS Pharma Pricing & Reimbursement 2007:224-227…
  • 2010
Highly Influential
7 Excerpts

Similar Papers

Loading similar papers…